CareCloud Reports Q3 Earnings Per Share of 10 Cents Compared to 21 Cents Last Year
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 06 2025
0mins
Should l Buy CCLD?
Q3 Revenue Growth: CareCloud reported Q3 revenue of $31.1 million, an increase from $28.5 million in the previous year.
Positive Outlook: The company raised its full-year 2025 revenue guidance, indicating strong performance and growth.
Impact of Acquisitions: The growth is attributed to the successful acquisitions of Medsphere and Map App, which have expanded CareCloud's presence in the hospital market.
Focus on Care Settings: The acquisitions have enhanced CareCloud's capabilities in both ambulatory and inpatient care settings.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CCLD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CCLD
Wall Street analysts forecast CCLD stock price to rise
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 2.910
Low
3.25
Averages
6.42
High
8.00
Current: 2.910
Low
3.25
Averages
6.42
High
8.00
About CCLD
CareCloud, Inc. is a provider of technology-enabled services and generative artificial intelligence (AI) solutions that redefine the healthcare revenue cycle management process. It provides technology-enabled revenue cycle management and a full suite of proprietary cloud-based solutions to healthcare providers, from small practices to enterprise medical groups, hospitals, and health systems throughout the United States. Its Healthcare IT segment includes technology-assisted revenue cycle management, software-as-a-service solutions and professional and other services. Its Medical Practice Management segment includes the management of three medical practices. Its technology-enabled business solutions include Technology-enabled revenue cycle management, Cloud-based software, Digital health, and Healthcare IT professional services & staffing. Its revenue cycle management services, including end-to-end medical billing, eligibility, analytics, and related services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
CareCloud to Announce Q4 Earnings on March 12
- Earnings Announcement: CareCloud (CCLD) is set to release its Q4 earnings report on March 12 before the market opens, drawing significant attention from investors regarding its performance.
- Earnings Expectations: The consensus EPS estimate stands at $0.04, reflecting an 83.3% year-over-year decline, indicating potential profitability challenges that could affect investor confidence.
- Revenue Forecast: The revenue estimate is projected at $32.1 million, representing a 13.8% year-over-year increase, suggesting the company maintains some resilience in revenue growth, which may attract long-term investors.
- Historical Performance: Over the past two years, CCLD has beaten EPS estimates 63% of the time and revenue estimates 75% of the time, demonstrating relative stability in financial forecasting that could reassure stakeholders.
See More
CareCloud Reports Strong Q4 Earnings Growth
- Significant Profit Growth: CareCloud reported a profit of $1.52 million in Q4, a substantial increase from $0.01 million in the same period last year, indicating strong performance and improved profitability in the market.
- Improved EPS: The earnings per share for Q4 reached $0.04, compared to $0.00 in the same period last year, demonstrating a notable advancement in the company's profitability and boosting investor confidence.
- Strong Adjusted Earnings: Excluding items, CareCloud reported adjusted earnings of $4.46 million or $0.11 per share, reflecting robust growth in the company's core business and an enhancement in earnings quality.
- Sustained Revenue Growth: Q4 revenue was $34.42 million, up 21.8% from $28.24 million in the same period last year, showcasing the company's ongoing expansion in customer base and market demand.
See More
CareCloud Q4 Earnings Report Analysis
- Earnings Performance: CareCloud reported a Q4 non-GAAP EPS of $0.07, missing expectations by $0.04, indicating pressure on profitability that may affect investor confidence.
- Revenue Growth: The company achieved Q4 revenue of $34.42 million, a 22.1% year-over-year increase, exceeding market expectations by $2.32 million, demonstrating strong demand in the healthcare IT sector.
- Fiscal Year 2026 Outlook: CareCloud projects FY 2026 revenue between $128 million and $132 million, with adjusted EBITDA expected to be between $29 million and $31 million, indicating future growth potential but raising concerns about profitability.
- EPS Guidance: The company anticipates GAAP EPS for FY 2026 to be between $0.20 and $0.23, and while revenue is growing, the lower end of the earnings forecast may raise market concerns regarding its long-term profitability.
See More
CareCloud Appoints New Executives to Accelerate AI Innovation
- Leadership Realignment: CareCloud announced that A. Hadi Chaudhry will become Chief Strategy Officer on January 1, 2026, focusing on enterprise AI development, aiming to drive growth in the healthcare technology sector through enhanced leadership.
- Financial Performance Improvement: Over the past two years, the company has significantly improved cash flow and margins, with expectations to achieve its first positive earnings per share in 2026, marking a continued enhancement of its financial health.
- Market Expansion: CareCloud has entered the inpatient software market through the acquisitions of Medsphere Systems and the HFMA MAP App, broadening its addressable market and further solidifying its position in the healthcare industry.
- Strategic Vision: New CEO Stephen Snyder emphasized a continued focus on execution and financial performance, driving AI-driven growth to ensure the company's long-term competitive advantage in the healthcare sector.
See More
CareCloud Appoints New Executives to Accelerate AI Innovation
- Leadership Realignment: CareCloud announced that A. Hadi Chaudhry will become Chief Strategy Officer on January 1, 2026, focusing on enterprise AI development, which aims to enhance the company's competitiveness in healthcare technology.
- Financial Performance Improvement: Over the past two years, the company has significantly improved cash flow and successfully entered the hospital software market, with expectations of achieving its first positive earnings per share in 2026, marking a major advancement in financial health.
- Market Expansion: CareCloud expanded into the inpatient software market through the acquisitions of Medsphere Systems and the HFMA MAP App, broadening its addressable market and strengthening its influence across the full care continuum.
- Strategic Focus: New CEO Stephen Snyder emphasized a continued focus on execution and margin expansion, ensuring the company maintains sustainable value in AI-driven growth, indicating strong future growth potential.
See More
Revvity Enhances AI-Powered Scientific Research with Signals Xynthetica
Introduction of Signals Xynthetica: Revvity, Inc. has launched Signals Xynthetica, an AI-augmented design platform aimed at enhancing molecular and materials discovery, integrating advanced design capabilities with experimental data in a Models-as-a-Service (MaaS) framework.
Addressing R&D Bottlenecks: The platform seeks to bridge the gap between computational models and experimental workflows, promoting a continuous learning loop that enhances predictive insights and aligns AI predictions with laboratory practices.
Strategic Evolution: Revvity is transitioning from providing standalone scientific tools to becoming a platform-centric technology partner, focusing on AI-driven insights and seamless integration of scientific data across various applications, including drug discovery and clinical laboratories.
Market Position and Future Prospects: While Revvity's stock performance has been modest compared to industry peers, the introduction of Signals Xynthetica and other AI initiatives positions the company for potential growth as demand for integrated predictive tools in scientific research increases.
See More
CareCloud to Announce Q4 Earnings on March 12
- Earnings Announcement: CareCloud (CCLD) is set to release its Q4 earnings report on March 12 before the market opens, drawing significant attention from investors regarding its performance.
- Earnings Expectations: The consensus EPS estimate stands at $0.04, reflecting an 83.3% year-over-year decline, indicating potential profitability challenges that could affect investor confidence.
- Revenue Forecast: The revenue estimate is projected at $32.1 million, representing a 13.8% year-over-year increase, suggesting the company maintains some resilience in revenue growth, which may attract long-term investors.
- Historical Performance: Over the past two years, CCLD has beaten EPS estimates 63% of the time and revenue estimates 75% of the time, demonstrating relative stability in financial forecasting that could reassure stakeholders.
See More
CareCloud Reports Strong Q4 Earnings Growth
- Significant Profit Growth: CareCloud reported a profit of $1.52 million in Q4, a substantial increase from $0.01 million in the same period last year, indicating strong performance and improved profitability in the market.
- Improved EPS: The earnings per share for Q4 reached $0.04, compared to $0.00 in the same period last year, demonstrating a notable advancement in the company's profitability and boosting investor confidence.
- Strong Adjusted Earnings: Excluding items, CareCloud reported adjusted earnings of $4.46 million or $0.11 per share, reflecting robust growth in the company's core business and an enhancement in earnings quality.
- Sustained Revenue Growth: Q4 revenue was $34.42 million, up 21.8% from $28.24 million in the same period last year, showcasing the company's ongoing expansion in customer base and market demand.
See More
CareCloud Q4 Earnings Report Analysis
- Earnings Performance: CareCloud reported a Q4 non-GAAP EPS of $0.07, missing expectations by $0.04, indicating pressure on profitability that may affect investor confidence.
- Revenue Growth: The company achieved Q4 revenue of $34.42 million, a 22.1% year-over-year increase, exceeding market expectations by $2.32 million, demonstrating strong demand in the healthcare IT sector.
- Fiscal Year 2026 Outlook: CareCloud projects FY 2026 revenue between $128 million and $132 million, with adjusted EBITDA expected to be between $29 million and $31 million, indicating future growth potential but raising concerns about profitability.
- EPS Guidance: The company anticipates GAAP EPS for FY 2026 to be between $0.20 and $0.23, and while revenue is growing, the lower end of the earnings forecast may raise market concerns regarding its long-term profitability.
See More
CareCloud Appoints New Executives to Accelerate AI Innovation
- Leadership Realignment: CareCloud announced that A. Hadi Chaudhry will become Chief Strategy Officer on January 1, 2026, focusing on enterprise AI development, aiming to drive growth in the healthcare technology sector through enhanced leadership.
- Financial Performance Improvement: Over the past two years, the company has significantly improved cash flow and margins, with expectations to achieve its first positive earnings per share in 2026, marking a continued enhancement of its financial health.
- Market Expansion: CareCloud has entered the inpatient software market through the acquisitions of Medsphere Systems and the HFMA MAP App, broadening its addressable market and further solidifying its position in the healthcare industry.
- Strategic Vision: New CEO Stephen Snyder emphasized a continued focus on execution and financial performance, driving AI-driven growth to ensure the company's long-term competitive advantage in the healthcare sector.
See More
CareCloud Appoints New Executives to Accelerate AI Innovation
- Leadership Realignment: CareCloud announced that A. Hadi Chaudhry will become Chief Strategy Officer on January 1, 2026, focusing on enterprise AI development, which aims to enhance the company's competitiveness in healthcare technology.
- Financial Performance Improvement: Over the past two years, the company has significantly improved cash flow and successfully entered the hospital software market, with expectations of achieving its first positive earnings per share in 2026, marking a major advancement in financial health.
- Market Expansion: CareCloud expanded into the inpatient software market through the acquisitions of Medsphere Systems and the HFMA MAP App, broadening its addressable market and strengthening its influence across the full care continuum.
- Strategic Focus: New CEO Stephen Snyder emphasized a continued focus on execution and margin expansion, ensuring the company maintains sustainable value in AI-driven growth, indicating strong future growth potential.
See More
Revvity Enhances AI-Powered Scientific Research with Signals Xynthetica
Introduction of Signals Xynthetica: Revvity, Inc. has launched Signals Xynthetica, an AI-augmented design platform aimed at enhancing molecular and materials discovery, integrating advanced design capabilities with experimental data in a Models-as-a-Service (MaaS) framework.
Addressing R&D Bottlenecks: The platform seeks to bridge the gap between computational models and experimental workflows, promoting a continuous learning loop that enhances predictive insights and aligns AI predictions with laboratory practices.
Strategic Evolution: Revvity is transitioning from providing standalone scientific tools to becoming a platform-centric technology partner, focusing on AI-driven insights and seamless integration of scientific data across various applications, including drug discovery and clinical laboratories.
Market Position and Future Prospects: While Revvity's stock performance has been modest compared to industry peers, the introduction of Signals Xynthetica and other AI initiatives positions the company for potential growth as demand for integrated predictive tools in scientific research increases.
See More
